Global and China Self-monitoring Blood Glucose Devices Market Insights, Forecast to 2027

Self-monitoring of blood glucose (SMBG) is an important component of modern therapy for diabetes mellitus. SMBG has been recommended for people with diabetes and their health care professionals in order to achieve a specific level of glycemic control and to prevent hypoglycemia. The goal of SMBG is to collect detailed information about blood glucose levels at many time points to enable maintenance of a more constant glucose level by more precise regimens. It can be used to aid in the adjustment of a therapeutic regimen in response to blood glucose values and to help individuals adjust their dietary intake, physical activity, and insulin doses to improve glycemic control on a day-to-day basis.
The classification of self-monitoring blood glucose (SMBG) devices includes strips, glucose meter and lancet. The revenue proportion of strips in 2017 is about 85.08%, and the proportion is in increasing trend from 2013 to 2017.

Market Analysis and Insights: Global and China Self-monitoring Blood Glucose Devices Market
This report focuses on global and China Self-monitoring Blood Glucose Devices market.
In 2020, the global Self-monitoring Blood Glucose Devices market size was US$ 8903.4 million and it is expected to reach US$ 11570 million by the end of 2027, with a CAGR of 3.4% during 2021-2027. In China the Self-monitoring Blood Glucose Devices market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Self-monitoring Blood Glucose Devices Scope and Market Size
Self-monitoring Blood Glucose Devices market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Self-monitoring Blood Glucose Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Self-monitoring Blood Glucose Devices market size by players, by Type, and by SaleChannel, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
Strips
Glucose Meter
Lancet
Other

Segment by SaleChannel
Public Hospital
Private Hospital
Clinics
Pharmacy Shops

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Roche Roche Diagnostics
Lifescan
Abbott Laboratories
Terumo
Ascensia(Bayer)